Diligence memo · auto-generated · as of July 2, 2026
Inso Biosciences Inc.
Inso Biosciences Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Inso Biosciences Inc. operates in Biotechnology, based in ITHACA.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Inso Biosciences Inc. has raised $1.8M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.8M on 2022-02-11.
Most recent recorded round closed around 2022-02-11.
Valuation (modeled)modeled
Provath models Inso Biosciences Inc. at approximately $32M (range $1.3M–$164M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.26× the median modeled value of Seed Biotechnology companies in 2022–2024 (207 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 4.4 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 26% of Biotechnology peers (4293 compared).
Modeled value ranks above 36% of those peers.
Closest niche peers: Mesentech Inc., Marlinspike Therapeutics, Inc., Microbial Machines, Inc., Pearl Diagnostics, Inc., Crossfire Medical Inc.
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.